Quinidine-digoxin interaction: Pharmacokinetics, underlying mechanism and clinical implications.

Nonlinear pharmacokinetics: clinical Implications.

Clinical implications of benzodiazepine pharmacokinetics.

Interleukins. Clinical pharmacokinetics and practical implications.

Digoxin pharmacokinetics: multicompartmental analysis and its clinical implications.

Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications.

Pharmacokinetics of heparin and of dermatan sulfate: clinical implications.

Interaction between the premotor processes of eye and hand movements: possible mechanism underlying eye-hand coordination.

Underlying mechanism of antimicrobial activity of chitosan microparticles and implications for the treatment of infectious diseases.

Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications.

Globular protein-coated Paclitaxel nanosuspensions: interaction mechanism, direct cytosolic delivery, and significant improvement in pharmacokinetics.

Vascular Adventitia Calcification and Its Underlying Mechanism.

The experimental and clinical aspects of beta cell function and its underlying mechanism.

[Mechanism of action and pharmacokinetics of rilpivirine].

Pharmacokinetics of loracarbef and interaction with acetylcysteine.

Selected aspects of the pharmacokinetics and metabolism of ethinyl estrogens and their clinical implications.

Rod-cone mechanism underlying the Purkinje shift.

The neural mechanism underlying ordinal numerosity processing.

A possible mechanism underlying conditioned pain modulation.

Clinical pharmacokinetics.

The underlying inflammatory chronic disease influences infliximab pharmacokinetics.

Drug interactions and clinical pharmacokinetics.

Beta-Cell Function and Its Underlying Mechanism 2015.

Morphine: pharmacokinetics and clinical practice.

NOX Activation by Subunit Interaction and Underlying Mechanisms in Disease.

Suggest Documents

Nonlinear pharmacokinetics: clinical Implications.

Clinical implications of benzodiazepine pharmacokinetics.

Interleukins. Clinical pharmacokinetics and practical implications.

Digoxin pharmacokinetics: multicompartmental analysis and its clinical implications.

Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications.

Pharmacokinetics of heparin and of dermatan sulfate: clinical implications.

Interaction between the premotor processes of eye and hand movements: possible mechanism underlying eye-hand coordination.

Underlying mechanism of antimicrobial activity of chitosan microparticles and implications for the treatment of infectious diseases.

Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications.

Globular protein-coated Paclitaxel nanosuspensions: interaction mechanism, direct cytosolic delivery, and significant improvement in pharmacokinetics.

Vascular Adventitia Calcification and Its Underlying Mechanism.

The experimental and clinical aspects of beta cell function and its underlying mechanism.

[Mechanism of action and pharmacokinetics of rilpivirine].

Pharmacokinetics of loracarbef and interaction with acetylcysteine.

Selected aspects of the pharmacokinetics and metabolism of ethinyl estrogens and their clinical implications.

Rod-cone mechanism underlying the Purkinje shift.

The neural mechanism underlying ordinal numerosity processing.

A possible mechanism underlying conditioned pain modulation.

Clinical pharmacokinetics.

The underlying inflammatory chronic disease influences infliximab pharmacokinetics.

Drug interactions and clinical pharmacokinetics.

Beta-Cell Function and Its Underlying Mechanism 2015.

Morphine: pharmacokinetics and clinical practice.

NOX Activation by Subunit Interaction and Underlying Mechanisms in Disease.

Quinidine-digoxin interaction: Pharmacokinetics, underlying mechanism and clinical implications.

Recommend Documents

Follow Us